We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.69B
AUM Growth
-$822M
Cap. Flow
-$1.14B
Cap. Flow %
-24.25%
Top 10 Hldgs %
55.86%
Holding
70
New
9
Increased
11
Reduced
30
Closed
13

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$104M
2
AMZN icon
Amazon
AMZN
+$66.3M
3
USFD icon
US Foods
USFD
+$56.4M
4
MTOR
MERITOR, Inc.
MTOR
+$36.2M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$25.6M

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$133M
2
WTW icon
Willis Towers Watson
WTW
+$111M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$110M
4
PARA
Paramount Global Class B
PARA
+$105M
5
COR icon
Cencora
COR
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 58.05%
2 Technology 9.88%
3 Industrials 8.96%
4 Materials 7.92%
5 Consumer Discretionary 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
26
Norfolk Southern
NSC
$76.8B
$51.6M 1.1%
173,203
-104,596
-38% -$29.2M
LGV.U
27
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$50M 1.07%
5,000,000
– –
EHC icon
28
Encompass Health
EHC
$12.5B
$48.5M 1.03%
934,954
+431,292
+86% +$22.2M
CHNG
29
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$47.7M 1.02%
2,230,811
-52,211
-2% -$1.09M
QSI icon
30
Quantum-Si Incorporated
QSI
$166M
$47.2M 1.01%
6,000,000
– –
BSX icon
31
Boston Scientific
BSX
$71.8B
$46.7M 0.99%
1,098,684
-964,613
-47% -$40.5M
MYGN icon
32
Myriad Genetics
MYGN
$296M
$46.4M 0.99%
1,679,747
-555,421
-25% -$16.1M
HOLX
33
DELISTED
Hologic
HOLX
$44.8M 0.96%
585,321
-114,684
-16% -$8.43M
UNP icon
34
Union Pacific
UNP
$176B
$43M 0.92%
170,579
-158,868
-48% -$37.6M
NSP icon
35
Insperity
NSP
$1.93B
$40.5M 0.86%
342,664
-168,594
-33% -$19.9M
MCK icon
36
CALL
McKesson
MCK
$101B
$39.8M 0.85%
160,000
– –
GOOGL icon
37
Alphabet (Google) Class A
GOOGL
$4.37T
$35.2M 0.75%
243,300
-761,940
-76% -$110M
GOOGL icon
38
PUT
Alphabet (Google) Class A
GOOGL
$4.37T
$34.8M 0.74%
+240,000
New +$34.6M
SABR icon
39
Sabre
SABR
$866M
$33.8M 0.72%
3,929,064
+221,592
+6% +$2.12M
BFLY icon
40
Butterfly Network
BFLY
$2.22B
$33.2M 0.71%
4,964,751
– –
AMGN icon
41
Amgen
AMGN
$218B
$30.3M 0.65%
134,645
+28,775
+27% +$6.07M
HUM icon
42
Humana
HUM
$43.4B
$25.5M 0.54%
54,978
-125,034
-69% -$55.3M
BHVN
43
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$21.8M 0.46%
157,835
+43,490
+38% +$5.53M
ATVI
44
DELISTED
Activision Blizzard
ATVI
$20.6M 0.44%
+309,132
New +$21.1M
FLEX icon
45
Flex
FLEX
$45.4B
$18.3M 0.39%
1,327,000
-153,984
-10% -$2.08M
IS
46
DELISTED
ironSource Ltd.
IS
$15.2M 0.32%
1,967,668
-2,169,434
-52% -$21.4M
DNB
47
DELISTED
Dun & Bradstreet
DNB
$15.1M 0.32%
734,595
– –
CHNG
48
CALL
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$10.7M 0.23%
+500,000
New +$10.5M
BABA icon
49
Alibaba
BABA
$303B
$9.84M 0.21%
+82,789
New +$12.1M
ENDP
50
DELISTED
Endo International plc
ENDP
$8.2M 0.17%
2,181,239
-4,368,065
-67% -$21.2M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Glenview Capital Management held 70 positions worth $4.69B, down 15% from $5.51B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Glenview Capital Management withdrew a net $1.14B in Q4 2021, closing 13 positions and reducing 30 holdings. Its most notable exit was Takeda Pharmaceutical, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Amazon worth $64.6M.

  • Glenview Capital Management's largest Q4 2021 buy was Amazon: 387,500 shares worth $64.6M.
  • Glenview Capital Management added most to Global Payments in Q4 2021, an estimated $104M increase.
  • Glenview Capital Management's biggest Q4 2021 reduction was Willis Towers Watson, cutting an estimated $111M.
  • Glenview Capital Management fully exited Takeda Pharmaceutical in Q4 2021, selling an estimated $133M.
  • Glenview Capital Management's ten largest holdings make up 56% of its $4.69B portfolio in Q4 2021.
  • Glenview Capital Management opened 9 new positions and closed 13 in Q4 2021.
  • Glenview Capital Management's portfolio value fell 15% quarter-over-quarter to $4.69B.

Based on Glenview Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.